Finance

Lists
PHM:BME
Pharma Mar SA
70,85 €
-0,77%
(-0,55) 1D
5 ოქტ, 13:21:22 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
71,30 €
High
71,55 €
Low
70,65 €
Mkt. cap
1,28 მლრდ.
Avg. vol.
30,33 ათ.
Volume
13,20 ათ.
Dividend
1,41%
Quarterly dividend
0,25 €
Ex-dividend date
7 ივნ. 2023
P/E ratio
21,56
52-wk high
105,20 €
52-wk low
64,00 €
EPS
3,29 €
Shares outstanding
18,00 მლნ.
No. of employees
505
Open
71,30 €
High
71,55 €
Low
70,65 €
Mkt. cap
1,28 მლრდ.
Avg. vol.
30,33 ათ.
Volume
13,20 ათ.
Dividend
1,41%
Quarterly dividend
0,25 €
Ex-dividend date
7 ივნ. 2023
P/E ratio
21,56
52-wk high
105,20 €
52-wk low
64,00 €
EPS
3,29 €
Shares outstanding
18,00 მლნ.
No. of employees
505
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
22 წუთის წინ
AI Chips Update - AIBotics Boosts AI Strategy with Empulser Acquisition
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
40 წუთის წინ
NYSE logo in New York City
Stock Titan
Stock Titan
·
53 წუთის წინ
After a 1-for-30 reverse split, Megan Holdings (Nasdaq: MGN) receives Nasdaq’s compliance decision.
MarketWatch
MarketWatch
·
19 წუთის წინ
An AI ‘reality check’ may take the S&P 500 to 5,000. Here’s the trades to make, this strategist says.
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
Sector-
Websitepharmamar.com
Last report
30 ივლ. 2026
Fiscal period
Q2 2026
EPS / Est. (EUR)
0,02 € / 0,18 €
-90,99%miss
Revenue / Est. (EUR)
92,50 მლნ. / 45,22 მლნ.
+104,55%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
35,66 მლნ.
90,48 მლნ.
42,90 მლნ.
49,60 მლნ.
Cost of goods sold
2,30 მლნ.
3,77 მლნ.
3,66 მლნ.
4,73 მლნ.
Cost of revenue
2,30 მლნ.
3,77 მლნ.
3,66 მლნ.
4,73 მლნ.
Research and development expenses
22,13 მლნ.
25,59 მლნ.
20,88 მლნ.
26,38 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,63 მლნ.
17,31 მლნ.
15,31 მლნ.
17,12 მლნ.
Operating expense
37,32 მლნ.
43,09 მლნ.
38,62 მლნ.
46,28 მლნ.
Total operating expenses
39,62 მლნ.
46,87 მლნ.
42,28 მლნ.
51,01 მლნ.
Operating income
-3,96 მლნ.
43,61 მლნ.
622,00 ათ.
-1,40 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-4,08 მლნ.
44,28 მლნ.
1,60 მლნ.
-993,00 ათ.
EBT excluding unusual items
-4,08 მლნ.
44,28 მლნ.
1,60 მლნ.
-993,00 ათ.
Income tax expense
24,00 ათ.
-15,39 მლნ.
65,00 ათ.
-21,00 ათ.
Effective tax rate
-0,59%
-34,75%
4,07%
2,11%
Other operating expenses
8,56 მლნ.
195,00 ათ.
2,43 მლნ.
2,77 მლნ.
Net income
-4,10 მლნ.
59,66 მლნ.
1,53 მლნ.
-972,00 ათ.
Net profit margin
-11,50%
65,95%
3,57%
-1,96%
Earnings per share
-
-
-
-
Interest and investment income
-
3,44 მლნ.
976,00 ათ.
412,00 ათ.
Interest expense
-117,00 ათ.
-724,00 ათ.
-
-
Net interest expenses
-117,00 ათ.
2,72 მლნ.
976,00 ათ.
412,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,95 მლნ.
45,64 მლნ.
2,71 მლნ.
700,00 ათ.
Gain or loss from assets sale
-10,00 ათ.
-754,00 ათ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები